Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • RFK Jr.’s Future
  • Melanoma Drug
  • Charity Care Gap
  • Search for New FDA Chief

WHAT'S NEW

  • RFK Jr.'s Future
  • Melanoma Drug
  • Charity Care Gap
  • Search for New FDA Chief

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Aug 13 2024

Full Issue

Viewpoints: Too Many Young People Are Getting Cancer; The Public Agrees On Free Tampon Access In Bathrooms

Editorial writers discuss these issues and others.

Scientific American: Cancer Rates Are Rising In Young People. Here’s What You Need To Know 

Today a woman in her 30s faces higher odds of a cancer diagnosis than her grandmother did at her age two generations ago. Cancer incidence and mortality are rising in millennials and even younger populations, according to American Cancer Society (ACS) data, while rates among older Americans are declining. (Karen E. Knudsen and Othman Laraki, 8/12)

The Boston Globe: Putting Free Tampons In All School Bathrooms Is Hardly A Radical Idea

At a time when fewer people carry cash — let alone loose coins — free access to menstrual products eliminates these absurdities, normalizes a bodily function that has been treated as dirty or shameful, and allows children, whatever their gender identity, to tend to a fundamental health need on their own terms. As panicky Republicans concoct insults and false accusations to puncture the rapid rise of the Harris-Walz ticket, they remain out of step with most Americans on menstrual equity. (Renee Graham, 8/11)

The New York Times: How A Supposedly Scientific Report Became A Weapon In The War On Trans Kids

In its upcoming term, the Supreme Court will once again hear a case that involves a highly contentious question that lies at the heart of personal liberty: Who should decide what medical care a person receives? Should it be patients and their families, supported by doctors and other clinicians, using guidelines developed by the leading experts in the field based on the most current scientific knowledge and treatment practice? Or does the Constitution permit lawmakers to place themselves, and courts, in the middle of some of the most complex and intimate decisions people will make in their lives? (Lydia Polgreen, 8/13)

Kansas City Star: Missouri Abortion Amendment May Have Unintended Consequences

This week, Missouri Secretary of State Jay Ashcroft is expected to certify Missourians for Constitutional Freedom’s proposed amendment to the Missouri Constitution. If approved by voters in November, this would enshrine a “right to reproductive freedom” in the Missouri Constitution. As a high school social studies teacher in St. Louis, this raises fascinating issues of law and policy that are as relevant to my advanced placement U.S. government and politics students, as they are to Missourians generally. It is important to appreciate the historical context for the initiative. (Robert P. Barnidge Jr., 8/13)

Stat: Health Equity: When $5 Aspirin Is As Good As A $300 Injection

There are few things more exciting for researchers than to mount and complete a clinical trial that could change the practice of medicine and save lives. That’s what we experienced when The New England Journal of Medicine published our findings in January 2023 that aspirin was as effective at preventing life-threatening blood clots after surgery as was a far more expensive and more painful injectable blood thinner. (Deborah M. Stein and Robert V. O'Toole, 8/13)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 15
  • Thursday, May 14
  • Wednesday, May 13
  • Tuesday, May 12
  • Monday, May 11
  • Friday, May 8
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF